ATN-161

Phase of research

Potential treatment - pre-clinical evidence

How it helps

Antiviral

Drug status

Experimental

Supporting references

Contradictory references

AI-suggested references

Clinical trials

Link	Tested on	Impact factor	Notes	Publication date
The Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV-2 Infection Preprint	VERO E6 cell cultures		inhibiting α5β1 integrin interaction with ACE2 and the spike protein	Jun/16/2020

Link	Publication date
In Vivo protection from SARS-CoV-2 infection by ATN-161 in k18-hACE2 transgenic mice	Oct/05/2021
Penta-peptide ATN-161 based neutralization mechanism of SARS-CoV-2 spike protein	Nov/10/2021